Argus

Boeing Co (NYSE: BA)'s stock has hit the skids following reports of two fatal Boeing plane crashes, and one Wall Street analyst said Tuesday he’s stepping to the sidelines until the causes and implications of the crashed are better understood. The Analyst Argus analyst John Eade...

Shares of Boeing Co (NYSE: BA) have appreciated a whopping 27 percent over the past quarter, versus a 3-percent increase in the S&P 500. Since the turn of 2019, the industrial sector has been boosted by constructive trade talks between the U.S. and China, according to Argus. The Analyst Argus...

The announcement that California utility company PG&E Corporation (NYSE: PCG) is preparing for bankruptcy sent shares of the battered stock tumbling more than 62 percent this week. However, a potential PG&E bankruptcy could also impact other utility stocks. Several Wall Street analysts have...

The extreme volatility in PG&E Corporation (NYSE: PCG) stock continued Friday after encouraging commentary from the California Public Utility Commission and an unlikely upgrade sent the stock skyrocketing more than 45 percent. What’s At Stake For traders who haven’t been following...

Despite falling nearly 60 percent over the past year, Argus said in a downgrade note that J C Penney Company Inc (NYSE: JCP) still carries "elevated risk" from a technical and fundamental perspective. The Analyst Analyst John Eade downgraded J.C. Penney from Hold to...

Based on cost efficient operations, strong market share and revenue boosting efforts, one analyst upgraded Clorox Co. (NYSE: CLX). The Analyst Argus analyst John Staszak upgraded Clorox from Hold to Buy and set a price target of $175. The Thesis Clorox has produced positive earnings per...

Southwest Airlines Co (NYSE: LUV) reported forecast-beating second-quarter results July 26, and an Argus analyst said Friday that the airline's fortunes will only improve from here.  The Analyst Analyst John Staszak upgraded Southwest Airlines from Hold to Buy and set a price target of $73...

Lululemon Athletica inc. (NASDAQ: LULU) got some love from one Wall Street analyst who said the company’s growth outlook is among the best in the entire retail industry. The Analyst Argus analyst John Staszak upgraded Lululemon from Hold to Buy and set a $150 price target for the stock. The...

Parker-Hannifin Corp (NYSE: PH), a manufacturer of motion and control technologies and systems to control fluids, gas or air, disappointed Argus in its fiscal 2019 outlook which prompted the research firm to downgrade the stock. The Analyst Argus' John Eade downgraded Parker-Hannifin from...

CBS Corporation (NYSE: CBS) has successfully stood out as a success story in an era of cord-cutting, but allegations of sexual misconduct against CEO Les Moonves and a legal battle with the Redstone family makes it difficult to hold a bullish stance, according to Argus.  The Analyst Argus...

Argus is downgrading Tupperware Brands Corp. (NYSE: TUP) due to falling revenue and what the sell-side firm sees as an inability to drive growth.  The Analyst Argus analyst Deborah Ciervo downgraded Tupperware from Hold to Sell. The Thesis Following the release of second-quarter...

Advanced Micro Devices, Inc. (NASDAQ: AMD) stock rose another 5.3 percent on Friday morning on top of Thursday's 15-percent move after a big earnings beat in the second quarter. One analyst says the stock may have even more upside ahead. The Analyst Argus analyst Jim Kelleher reiterated his Buy...

General Electric Company (NYSE: GE) stock is down more than 5 percent since reporting its second-quarter earnings numbers last week. Analysts still see a tough road ahead for GE and its investors, but some are surprised at the severity of the sell-off. Argus Downgrade Argus analyst John Eade in a...

The near-term doesn't hold out much promise for Carnival Corp (NYSE: CCL), according to an analyst at Argus. The Analyst John Staszak downgraded shares of Carnival from Buy to Hold. The Thesis Carnival is in for a turbulent near-term due to the challenges posed by "difficult prior-year...

A sell-side analyst cited product supply and manufacturing issues, as well as sales declines, in a Friday downgrade of medical device maker Zimmer Biomet Holdings Inc (NYSE: ZBH). The Analyst  Argus analyst David Toung downgraded Zimmer Biomet from Buy to Hold. The Thesis Zimmer has ...